In conclusion, our finding suggested that salidroside could ameliorate hypoxia‐induced liver oxidative stress and inflammation via Nrf2 and JAK2/STAT3 signaling pathways, which is likely to be a therapeutic candidate for the prevention and treatment of liver disorders at high altitudes. This evidence concerns the gene NFE2L2 and liver disorder.